Total Payments
$966.73
2023 Payments
$14.83
Companies
13
Transactions
15
Medicare Patients
4,831
Medicare Billing
$1.8M
Payment Breakdown by Category
Other$500.00 (51.7%)
Food & Beverage$342.52 (35.4%)
Education$124.21 (12.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $500.00 | 1 | 51.7% |
| Food and Beverage | $342.52 | 11 | 35.4% |
| Education | $124.21 | 3 | 12.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $621.13 | 3 | $0 (2019) |
| Onkos Surgical, Inc. | $153.12 | 1 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $23.88 | 1 | $0 (2019) |
| Eisai Inc. | $22.02 | 1 | $0 (2020) |
| Exelixis Inc. | $22.02 | 1 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $18.79 | 1 | $0 (2020) |
| Bayer HealthCare Pharmaceuticals Inc. | $18.01 | 1 | $0 (2019) |
| Amgen Inc. | $17.20 | 1 | $0 (2019) |
| Global Blood Therapeutics, Inc. | $16.22 | 1 | $0 (2021) |
| Lilly USA, LLC | $14.83 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $14.83 | 1 | Lilly USA, LLC ($14.83) |
| 2021 | $41.43 | 3 | Global Blood Therapeutics, Inc. ($16.22) |
| 2020 | $40.81 | 2 | Eisai Inc. ($22.02) |
| 2019 | $756.36 | 7 | Incyte Corporation ($522.13) |
| 2018 | $14.30 | 1 | Seattle Genetics, Inc. ($14.30) |
| 2017 | $99.00 | 1 | Incyte Corporation ($99.00) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/21/2023 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Oncology | ||||||
| 12/22/2021 | Global Blood Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $16.22 | General |
| 10/14/2021 | Seagen Inc. | ADCETRIS (Biological) | Education | In-kind items and services | $13.29 | General |
| Category: Oncology | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 02/14/2020 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $18.79 | General |
| 01/30/2020 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $22.02 | General |
| Category: Oncology | ||||||
| 12/17/2019 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Oncology | ||||||
| 10/24/2019 | Amgen Inc. | XGEVA (Biological) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Oncology | ||||||
| 10/03/2019 | Onkos Surgical, Inc. | — | Food and Beverage | Cash or cash equivalent | $153.12 | General |
| Category: ELEOS LIMB SALVAGE SYSTEM | ||||||
| 08/22/2019 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Oncology | ||||||
| 03/27/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Oncology | ||||||
| 03/06/2019 | Incyte Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| 03/06/2019 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $22.13 | General |
| Category: Hematology/Oncology | ||||||
| 11/27/2018 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Oncology | ||||||
| 08/18/2017 | Incyte Corporation | — | Education | Cash or cash equivalent | $99.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 854 | 16,160 | $1.1M | $280,899 |
| 2022 | 45 | 1,265 | 22,688 | $1.7M | $344,482 |
| 2021 | 42 | 1,299 | 26,844 | $1.9M | $446,944 |
| 2020 | 45 | 1,413 | 40,744 | $2.8M | $682,932 |
Total Patients
4,831
Total Services
106,436
Medicare Billing
$1.8M
Procedure Codes
162
All Medicare Procedures & Services
162 procedure records from CMS Medicare Utilization — Page 2 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1626 | Injection, granisetron hydrochloride, 100 mcg | Office | 2023 | 21 | 390 | $9,360 | $109.51 | 1.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 41 | 853 | $853.00 | $79.18 | 9.3% |
| J7030 | Infusion, normal saline solution , 1000 cc | Office | 2023 | 17 | 21 | $399.00 | $40.64 | 10.2% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 24 | 38 | $266.00 | $31.78 | 11.9% |
| J3490 | Unclassified drugs | Office | 2023 | 16 | 24 | $192.00 | $13.92 | 7.3% |
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2022 | 16 | 5,000 | $657,600 | $184,821 | 28.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 14 | 2,100 | $125,640 | $36,028 | 28.7% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 95 | 202 | $142,814 | $21,677 | 15.2% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2022 | 11 | 17 | $81,634 | $20,257 | 24.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 137 | $50,416 | $12,809 | 25.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 24 | 69 | $34,224 | $9,714 | 28.4% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2022 | 11 | 39 | $6,240 | $6,218 | 99.6% |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2022 | 11 | 828 | $23,184 | $5,385 | 23.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 78 | $19,500 | $5,089 | 26.1% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 11 | 33 | $121,275 | $4,558 | 3.8% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 18 | 67 | $14,137 | $3,980 | 28.2% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2022 | 70 | 317 | $34,236 | $3,881 | 11.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 51 | 72 | $22,536 | $3,778 | 16.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 16 | 34 | $12,138 | $2,731 | 22.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 67 | 243 | $15,552 | $2,533 | 16.3% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2022 | 22 | 54 | $18,576 | $2,450 | 13.2% |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | Office | 2022 | 11 | 18 | $9,000 | $2,414 | 26.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 73 | 292 | $10,512 | $2,238 | 21.3% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2022 | 12 | 20 | $13,140 | $1,902 | 14.5% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2022 | 25 | 53 | $8,533 | $1,235 | 14.5% |
About Dr. Vinh Trang, M.D
Dr. Vinh Trang, M.D is a Hematology & Oncology healthcare provider based in Olympia, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2012. The National Provider Identifier (NPI) number assigned to this provider is 1477810612.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vinh Trang, M.D has received a total of $966.73 in payments from pharmaceutical and medical device companies, with $14.83 received in 2023. These payments were reported across 15 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($500.00).
As a Medicare-enrolled provider, Trang has provided services to 4,831 Medicare beneficiaries, totaling 106,436 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 162 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Olympia, WA
- Active Since 04/12/2012
- Last Updated 09/03/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1477810612
Products in Payments
- ADCETRIS (Biological) $27.59
- LYNPARZA (Drug) $23.88
- JAKAFI (Drug) $22.13
- Cabometyx (Drug) $22.02
- Lenvima (Drug) $22.02
- Xofigo (Drug) $18.01
- XGEVA (Biological) $17.20
- VERZENIO (Drug) $14.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Olympia
Min Kang, Md, MD
Hematology & Oncology — Payments: $18,182
Hematology & Oncology $18,182
Ahmad Fora, Md, MD
Hematology & Oncology — Payments: $12,047
Hematology & Oncology $12,047
Dr. Shanthi Srinivas, M.d, M.D
Hematology & Oncology — Payments: $6,466
Hematology & Oncology $6,466
Dr. Jennifer Dacus, Md, MD
Hematology & Oncology — Payments: $457.61
Hematology & Oncology $457.61
Monique Semien, Md, MD
Hematology & Oncology — Payments: $70.37
Hematology & Oncology $70.37